According to Quotient's latest financial reports the company's current earnings (TTM) are -$88.79 M. In 2021 the company made an earning of -$0.11 B a decrease over its 2020 earnings that were of -$69.76 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | -$88.79 M | -17.75% |
2021 | -$0.11 B | 54.74% |
2020 | -$69.76 M | -11.48% |
2019 | -$78.8 M | -2.94% |
2018 | -$81.19 M | 20.2% |
2017 | -$67.54 M | 1.47% |
2016 | -$66.57 M | 188.24% |
2015 | -$23.1 M | -61.35% |
2014 | -$59.75 M | 905.28% |
2013 | -$5.95 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Atossa Therapeutics ATOS | -$29.84 M | -66.40% | ๐บ๐ธ USA |
Chembio Diagnostics CEMI | -$23.45 M | -73.59% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | -$20.53 M | -76.89% | ๐บ๐ธ USA |